Showing 4561-4580 of 7110 for: Cochrane Systematic Reviews Back
- Oral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infants
Cochrane Systematic Reviews, 28-Aug-2011
Rotavirus infection is the most common neonatal nosocomial viral infection. It is a major health problem worldwide. Epidemics with the newer P(6)G9 strains have been reported in neonatal units globally. These strains can cause severe symptoms in most infe
- Oral immunotherapy for milk allergy
Cochrane Systematic Reviews, 16-Oct-2012
The mainstay of treatment of IgE-mediated cow milk allergy (IMCMA) is an avoidance diet, which is especially difficult with a ubiquitous food like milk. Milk oral immunotherapy (MOIT) may be an alternative treatment, through desensitization or induction o
- Oral iron supplements for children in malaria-endemic areas
Cochrane Systematic Reviews, 26-Feb-2016
Iron-deficiency anaemia is common during childhood. Iron administration has been claimed to increase the risk of malaria.
- Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants
Cochrane Systematic Reviews, 11-Feb-2015
Lactoferrin, a normal component of human colostrum and milk, can enhance host defense and may be effective in the prevention of sepsis and necrotizing enterocolitis (NEC) in preterm neonates.
- Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates
Cochrane Systematic Reviews, 28-Aug-2011
Neonatal sepsis and necrotizing enterocolitis (NEC) cause significant neonatal mortality and morbidity in spite of appropriate antibiotic therapy. Enhancing host defence and modulating inflammation by using lactoferrin as an adjunct to antibiotics in the
- Oral methylxanthines for bronchiectasis
Cochrane Systematic Reviews, 8-Mar-2010
Bronchiectasis is characterised by chronic sputum production, bronchial wall dilation, recurrent infection and airflow limitation. Methylxanthines are used in the management of airflow limitation associated with asthma and COPD, where they are also purpor
- Oral misoprostol for induction of labour
Cochrane Systematic Reviews, 13-Jun-2014
Misoprostol is an orally active prostaglandin. In most countries misoprostol is not licensed for labour induction, but its use is common because it is cheap and heat stable.
- Oral morphine for cancer pain
Cochrane Systematic Reviews, 25-Apr-2014
This is the second updated version of a Cochrane review first published in Issue 4, 2003 of The Cochrane Library and first updated in 2007. Morphine has been used for many years to relieve pain. Oral morphine in either immediate release or modified releas
- Oral naltrexone maintenance treatment for opioid dependence
Cochrane Systematic Reviews, 27-Feb-2011
Research on clinical application of oral naltrexone agrees on several things. From a pharmacological perspective, naltrexone works. From an applied perspective, the medication compliance and the retention rates are poor.
- Oral non steroid anti-inflammatories for children and adults with bronchiectasis
Cochrane Systematic Reviews, 23-Mar-2009
Bronchiectasis is increasing recognised as a co-morbidity in many respiratory illness. Anti inflammatory drugs may reduce the inflammatory cascade and thus reduce symptoms and slow long term pulmonary decline.
- Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
Cochrane Systematic Reviews, 13-Jun-2013
Progressive lung damage causes most deaths in cystic fibrosis (CF). Non-steroidal anti-inflammatory drugs (NSAIDs) may prevent progressive pulmonary deterioration and morbidity in CF.
- Oral non‐steroidal anti‐inflammatory drugs (single dose) for perineal pain in the early postpartum period
Cochrane Systematic Reviews, 11-Jan-2021
Many women experience perineal pain after childbirth, especially after having sustained perineal trauma. Perineal pain-management strategies are an important part of postnatal care. Non-steroidal anti-inflammatory drugs (NSAIDs) are a commonly-used type o
- Oral nonsteroidal anti-inflammatory drugs for neuropathic pain
Cochrane Systematic Reviews, 14-Oct-2015
Although often considered to be lacking adequate evidence, nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in the management of neuropathic pain. Previous surveys found 18% to 47% of affected people reported using NSAIDs specifically for the
- Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury
Cochrane Systematic Reviews, 25-Jun-2015
Acute soft tissue injuries are common and costly. The best drug treatment for such injuries is not certain, although non-steroidal anti-inflammatory drugs (NSAIDs) are often recommended.
- Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
Cochrane Systematic Reviews, 11-Nov-2008
Hot flushes and night sweats are common symptoms experienced by menopausal women. Hormone therapy (HT), containing oestrogens alone or oestrogens together with progestogens in a cyclic or continuous regimen, is often recommended for their alleviation.
- Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
Cochrane Systematic Reviews, 2-Jul-2014
Iron deficiency is a significant cause of deferral in people wishing to donate blood. If iron removed from the body through blood donation is not replaced, then donors may become iron deficient. All donors are screened at each visit for low haemoglobin (H
- Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children
Cochrane Systematic Reviews, 3-Apr-2011
Otitis media with effusion (OME) is common and may cause hearing loss with associated developmental delay. Treatment remains controversial.
- Oral or transdermal opioids for osteoarthritis of the knee or hip
Cochrane Systematic Reviews, 13-Sep-2014
Osteoarthritis is the most common form of joint disease and the leading cause of pain and physical disability in older people. Opioids may be a viable treatment option if people have severe pain or if other analgesics are contraindicated. However, the evi
- Oral paliperidone for schizophrenia
Cochrane Systematic Reviews, 18-Apr-2012
Paliperidone, an active metabolite of risperidone, is now available in an oral formulation for daily use; an intramuscular formulation for monthly administration is expected to follow shortly. Oral paliperidone is available commercially only in an extende
- Oral potassium iodide for the treatment of sporotrichosis
Cochrane Systematic Reviews, 9-Aug-2009
Sporotrichosis is a subacute or chronic disease, usually affecting the skin caused by a dimorphic (existing in two forms), aerobic (oxygen requiring) fungus called Sporothrix schenckii. Oral potassium iodide is widely used for cutaneous sporotrichosis in
